My watch list
my.chemeurope.com  
Login  

A series of new terphenyl benzimidazoles (3a–z and 3aa–ad) were synthesized and evaluated for their anticancer activity. All the 30 compounds have shown moderate to good anticancer potency, however some of the compounds (3j, 3m−t and 3aa−ad) exhibited prominent anticancer potency with GI50 values ranging from <0.1 to 9.72 μM. These compounds exhibit G2/M phase arrest and the analysis of tubulin by Western blot experiments in case of 3t and 3ad shows the disturbances that are caused in the ratio of soluble versus polymerized tubulin in cells. Compounds 3t and 3ad are the most promising candidates amongst the series and has the potential to be taken up for further detailed studies either alone or in combination with the existing therapies.
Graphical Abstract Highlights A library of terphenyl benzimidazole compounds were prepared and evaluated for anticancer activity. Further, some of the biological assays were also carried.

  • ► 30 Novel terphenyl benzimidazoles were synthesized and evaluated for their anticancer potency. ► Suzuki coupling reaction has been utilized. ► G2/M phase arrest in A-549 cell lines. ► Inhibition’ of tubulin polymerization. ► Compounds 3t and 3ad could be promising anticancer agents for anticancer chemotherapy.

    Authors:   Ahmed Kamal, M. Kashi Reddy, Thokhir B. Shaik, Rajender, Y.V.V. Srikanth, V. Santhosh Reddy, G. Bharath Kumar, Shasi V. Kalivendi
    Journal:   European Journal of Medicinal Chemistry
    Year:   2012
    DOI:   10.1016/j.ejmech.2012.01.004
    Publication date:   23-04-2012
  • Watchlist

    This is where you can add this publication to your personal favourites.

    Additional Information

    Facts, background information, dossiers
    More about Elsevier
    Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE